Publication of Supplemental Prospectus

The following supplemental prospectus has been approved by the UK Listing Authority and is available for viewing:

Supplemental Prospectus dated 3 December 2014 (the "Supplemental Prospectus") to the prospectus dated 21 November 2014 (the "Prospectus"), relating to Prudential PLC's £5,000,000,000 Medium Term Note Programme (the "Programme").

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/7464Y_-2014-12-3.pdf

A copy of the Supplemental Prospectus and the documents incorporated by reference therein have also been submitted to the National Storage Mechanism and will shortly be available for inspection atwww.Hemscott.com/nsm.do

This site is not provided for, or directed at, persons in the United States. If you are viewing this page from the United States, you should exit this section of the site.

Prudential PLC is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America.

Enquiries to:

Media


Investors/Analysts


Jonathan Oliver

+44 (0)20 7548 3719

Raghu Hariharan

+44 (0)20 7548 2871

Ben Davies

+44 (0)20 7004 8082

Richard Gradidge

+44 (0)20 7548 3860

DISCLAIMER

Please note that the information contained in the Supplemental Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus (as supplemented by the Supplemental Prospectus) is not addressed. Prior to relying on the information contained in the Prospectus (as supplemented by the Supplemental Prospectus) you must ascertain from the Prospectus (as supplemented by the Supplemental Prospectus) whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Neither the Prospectus nor the Supplemental Prospectus constitutes an offer of securities for sale in the United States. The securities described in the Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, or under any relevant securities laws of any state of the United States of America and may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. Persons, subject to certain limited exemptions.


This information is provided by RNS
The company news service from the London Stock Exchange
ENDPDIXXLFBZLFBFBX
distributed by